| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.55e-04 | 56 | 39 | 3 | GO:0008023 | |
| GeneOntologyCellularComponent | chromatin | 2.92e-04 | 1480 | 39 | 10 | GO:0000785 | |
| MousePheno | small epididymis | 1.64e-05 | 70 | 31 | 4 | MP:0004930 | |
| Domain | ANK_REPEAT | 1.53e-03 | 253 | 37 | 4 | PS50088 | |
| Domain | ANK_REP_REGION | 1.55e-03 | 254 | 37 | 4 | PS50297 | |
| Domain | Ank_2 | 8.76e-03 | 215 | 37 | 3 | PF12796 | |
| Domain | Ank | 1.03e-02 | 228 | 37 | 3 | PF00023 | |
| Pubmed | Sequence analysis of 497 mouse brain ESTs expressed in the substantia nigra. | 3.87e-06 | 3 | 40 | 2 | 9027501 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 1.34e-04 | 1005 | 40 | 7 | 19615732 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.40e-04 | 774 | 40 | 6 | 15302935 | |
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 4.12e-04 | 26 | 40 | 2 | 33298525 | |
| Pubmed | 5.92e-04 | 1285 | 40 | 7 | 35914814 | ||
| Pubmed | FBXO38 Ubiquitin Ligase Controls Centromere Integrity via ZXDA/B Stability. | 6.26e-04 | 32 | 40 | 2 | 35813202 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 6.37e-04 | 608 | 40 | 5 | 36089195 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 6.91e-04 | 150 | 40 | 3 | 28242625 | |
| Pubmed | 7.62e-04 | 963 | 40 | 6 | 28671696 | ||
| Pubmed | 8.37e-04 | 37 | 40 | 2 | 22432025 | ||
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 1.03e-03 | 41 | 40 | 2 | 20431927 | |
| Pubmed | 1.10e-03 | 1429 | 40 | 7 | 35140242 | ||
| Interaction | SYT2 interactions | 3.49e-07 | 150 | 38 | 6 | int:SYT2 | |
| Disease | Bone Diseases, Developmental | 5.85e-04 | 27 | 39 | 2 | C0005941 | |
| Disease | Congenital Heart Defects | 1.55e-03 | 44 | 39 | 2 | C0018798 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 6.07e-03 | 88 | 39 | 2 | EFO_0803332 | |
| Disease | longevity | 6.24e-03 | 284 | 39 | 3 | EFO_0004300 | |
| Disease | eye color | 6.34e-03 | 90 | 39 | 2 | EFO_0003949 | |
| Disease | vascular endothelial function measurement | 7.62e-03 | 99 | 39 | 2 | EFO_0803369 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AAQPAHDSGHGDDES | 36 | Q8WV16 | |
| LSSEENDHPFHQGEG | 11 | P07307 | |
| QECHNHSPDGDSSSD | 61 | Q99767 | |
| SGASIEDHNENGHTP | 356 | O75179 | |
| HASNNQHGADSENGD | 356 | Q9UI36 | |
| GEHAESEHASGEPAA | 86 | P26436 | |
| SEPSHHNSEGADNSR | 411 | Q9UHB7 | |
| HSDFSASNGNPDLHL | 1136 | Q8TDY8 | |
| AHQDNPHEGEDQVSD | 221 | Q9UH92 | |
| NNSGHESHSPALADS | 5131 | Q8WXI7 | |
| VEDENDHAPTFGSAH | 1741 | Q96JQ0 | |
| RAHNGATPAHDAAAT | 66 | Q6ZVH7 | |
| HEDNDPSDVDQHSGS | 96 | Q8WVC0 | |
| ADSQHESQHGGLDQD | 616 | Q8NFM7 | |
| HAHPGAAAAAAAAAA | 116 | P50219 | |
| ALNGDSHISEHPAEN | 546 | Q8WYN3 | |
| PQNHEGNHTSADENE | 46 | A8MYZ0 | |
| PDHDHAGQGTESEEQ | 431 | Q9NP56 | |
| SANHHADNPRHGSSE | 231 | Q6KC79 | |
| PGSHSENALHASEEE | 351 | Q9BZL6 | |
| NNHHHPDDSDEENDF | 511 | Q6PIJ6 | |
| GDNADASQEHVSFHV | 16 | P29017 | |
| HNHEDDVLGFPSNQD | 216 | O95273 | |
| ANDGAPDHETASNHA | 1076 | Q6IMN6 | |
| GNSHVHSTDDPEAAR | 126 | Q9NUM3 | |
| DEGHSNSSPRHSEAA | 76 | Q14103 | |
| DEANANANLHGDPSE | 116 | Q96KW9 | |
| DHFHAEQGSPAEQGD | 771 | Q587J7 | |
| DQAADSDHPSSAHSD | 6 | Q02577 | |
| SQENSHNHGDGAEDF | 126 | O75182 | |
| NSDSGQDAHPDPDAN | 151 | Q9BUA3 | |
| VDGGSQDHSHSEQDD | 56 | Q8WXE9 | |
| HLEHSEQNPGSSAGD | 66 | Q8ND24 | |
| NGTAAHPHAHAASEV | 836 | Q5W0Q7 | |
| SEAAEAQHGPHSAVA | 111 | O75558 | |
| AAASGQDPHSSQAFH | 666 | Q96HA7 | |
| EDDGGHNDHSQPQAS | 1241 | Q92610 | |
| AGHTDGPHSQTAEAD | 641 | O95359 | |
| NSHHSQPERQDGDSH | 131 | Q6XPR3 | |
| HEPQLAAAHTDGASE | 136 | Q13488 |